This article explores the interplay between CSCs and the paracrine renin–angiotensin system in the melanoma TME, and their interaction with the dysregulated Ras/RAF/MAPK/ERK and PI3K/AKT/mTOR signaling pathways, highlighting their implications on current therapeutic approaches. Here, MTOR is linked to melanoma.